There are not many opportunities like this nowadays. As usual, there's no such thing called guaranteed investment. Make the most of it as long as one do not sell his kidney to invest.

@ Lee_CK, China National Pharmaceutical Group is Sinopharm. Distributed by Kanger.

MadCow, if I may add, the way I see things and with investment incentives eg pioneer status or whatever, you bet many counters will announce they are into this business as well. But it is the pioneer counters like Kanger will skim the market first. Right now, I do not see any other competitors coming close unless someone suddenly announce they teamed up with Sinovac or Astra Zennecca.

We are here to make most out of the stock market. We see the potential and therefore we invest. We hold as long as possible, make money and exit. We do not fall in love with the counters. And this love affair will peak at most 1 year.

MadCow, I agree with you. Companies like Bintai or HWGB they are into vaccine business but nowhere near completion. Then you have Solution until now did not see distribution network as they are engineering solutions biz. But they are good in press releases. :)

But prices will fly super high when one get approvals and it looked like Sinopharm very high chances.

Definitely many suppliers. Impossible to have just 1 supplier, volume too big, risk too high.

Seemed like vaccine Covid19 cost got Income tax exemption

Seemed like vaccine Covid19 cost got Income tax exemption

Seemed like vaccine Covid19 cost got Income tax exemptions

KUALA LUMPUR, Nov 6 — The government has decreased next year’s budgets for curative care and public health, including deep cuts for cancer and kidney disease treatments, even as Malaysia is facing the greatest public health crisis in history with Covid-19.

Despite a slight 4 per cent increase of the Ministry of Health’s (MOH) allocation from last year to RM31.9 billion in Budget 2021, MOH reduced its medical budget by 20.5 per cent from RM14.2 billion in 2020 to RM11.3 billion in 2021, making wide-ranging cuts across almost all health care services, including a massive 74 per cent decrease for pharmacy and supplies, according to the Estimated Federal Expenditure 2021 document. Pharmacy and supplies refer to drugs and other non-pharmaceutical items like personal protective equipment, IV drips, and syringes, among others.

KUALA LUMPUR, Nov 6 — The government has decreased next year’s budgets for curative care and public health, including deep cuts for cancer and kidney disease treatments, even as Malaysia is facing the greatest public health crisis in history with Covid-19.

Despite a slight 4 per cent increase of the Ministry of Health’s (MOH) allocation from last year to RM31.9 billion in Budget 2021, MOH reduced its medical budget by 20.5 per cent from RM14.2 billion in 2020 to RM11.3 billion in 2021, making wide-ranging cuts across almost all health care services, including a massive 74 per cent decrease for pharmacy and supplies, according to the Estimated Federal Expenditure 2021 document. Pharmacy and supplies refer to drugs and other non-pharmaceutical items like personal protective equipment, IV drips, and syringes, among others.

And middleman for private hospital vaccines too..that's where the money is compared to Government hospital supplies which is not much profit.

How come everyone say Pharmaniaga and DuoPharma are officially Covid19 distributors?
====================================================================

KUALA LUMPUR, July 28 — Minister Khairy Jamaluddin clarified in Parliament today that the government has not selected local pharmaceutical companies — Pharmaniaga Bhd and Duopharma Biotech Bhd — to undertake fill-finish processing for any Covid-19 vaccine.

The minister of science, technology and innovation told the Dewan Rakyat that the two government-linked companies were simply identified as pharmaceutical corporations with the capacity to conduct fill-finish processing, which is a process where the active agent of the pharmaceutical product is formulated or mixed into its final form (like liquid or powder), and filling and sealing it within final containers (like prefilled syringes).


https://codeblue.galencentre.org/2020/07/28/minister-clarifies-pharmaniaga-duopharma-not-appointed-for-covid-19-vaccine-fill-finish/

Manufacturer need to certify refilling facilities meet their standard before they let you refill...it is not as simple as people think. That too only if manufacturer cannot cope up and no one wants to transfer their technology to others.

Pharmaniaga can fill but does manufacturer want to supply in bulk?
-----------------------------------------------------------------------------------------

Pharmaniaga is one of few companies identified by the government recently to use their
existing facilities for bottling the vaccine when it becomes available.

Mohamed Iqbal, however, noted that although Malaysia has the capacity to do the fill and
finish process, it also depends on how much vaccine can be supplied by the
manufacturer.

“That’s the challenge, because countries worldwide are placing in their orders for large
populations. On our part, we are ready and we have been doing testing so that when the
vaccine is ready, we should be able to do the fill and finish process almost immediately,”
he told a media briefing today.

Money is one thing. The soft skills and expertise is another. It will take time to build up. And not many players in the market for you to pinch the staff.

Repackaging is not a simple process. It need sterile environment, absolute clean room standard, no chances of contamination, super strict quality control, specialised automated equipment, labelling, logistics support and temperature controlled packaging. And not to forget the qualified people.

But after you got all these in place, you need accreditation from regulators, certifications, etc. That will take a long time.

Profit taking already yesterday. Next week should go up. But operator might want to stabilise pre PP price. So my take is prices will move Wed onwards.

Tengku Zafrul added that to encourage Malaysians to get preventive vaccinations to curb the spread of diseases, the government would also expand the scope of tax exemption for the medical treatment covering vaccination expenses such as pneumococcal, influenza and Covid-19.

He also said tax exemption would be given for the vaccination cost for personal, spouse and children with a limit up to RM1,000.

Tengku Zafrul added that to encourage Malaysians to get preventive vaccinations to curb the spread of diseases, the government would also expand the scope of tax exemption for the medical treatment covering vaccination expenses such as pneumococcal, influenza and Covid-19.

He also said tax exemption would be given for the vaccination cost for personal, spouse and children with a limit up to RM1,000.

Bintai for Generalex, Solution for Cansino , Kanger for Sinopharm....all vaccines. Which one is the first to be approved?

It is good to see high volume. Means investors are coming in and Kanger is in the limelight. Most important the interest is there. Prices will move when all these happen.

Not many know Kanger signed 2 agreements enroute to obtain the rights distribute Sinopharm.

It is a MOU. Not an agreement yet. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3099656

A bit surprised more than 200m shares exchanged hands today and prices did not move. Who is collecting?

Even the ruler of UAE took the vaccine. What other proof you need? hehehe..

Don't think there are many days left to collect cheaply.

I am a extremely patient man....I will get my RM 10...hahahahahaha...

I believe private hospitals and clinics would be offering vaccinations and personal tax reliefs is for that. This is where Zuellig comes in to manage distribution to the private sector.

That's what I noticed...2 or 3 sellers and 7 or 8 buyers

I am talking about Kstar la

Ownself play ownself also can play until out of control. LOL

PP exercise going on and the suggested price is .178. So with a discount of 10%, the price should hover aroound .19 to .20 for next few days. At least that my thoughts.

This is how serious Covid19 situation in Sabah. We really need Vaccine. It can be Sinopharm, Sinovax, Cansino, whatever.

https://codeblue.galencentre.org/2020/10/23/its-everywhere-sabah-ground-zero-of-malaysia-covid19-epidemic/

I normally vary of such stock. You can get caught very easily.

Somehow I find Kstar a bit wierd. Prices may fly but sellers and buyers very few.

Kanger is the priority distributor for Sinopharm in Malaysia.

Covac only supply Malaysia 10% vaccine. The rest Gomen have to buy from suppliers / distributors.

Expectations are high with big budget for vaccines

KUALA LUMPUR, Oct 13 — A Covid-19 vaccine from China may be deployed in Malaysia by the end of the year, Muhyiddin Yassin said today.
........................

"At the same time, the prime minister also stated that Malaysia can make its own bilateral agreements outside COVAX, such as with China’s state-owned pharmaceutical company Sinopharm or British-Swedish pharmaceutical company AstraZeneca, to obtain Covid-19 vaccines for Malaysia."

https://codeblue.galencentre.org/2020/10/13/malaysia-may-get-chinese-c...

KUALA LUMPUR, Oct 13 — A Covid-19 vaccine from China may be deployed in Malaysia by the end of the year, Muhyiddin Yassin said today.
........................

"At the same time, the prime minister also stated that Malaysia can make its own bilateral agreements outside COVAX, such as with China’s state-owned pharmaceutical company Sinopharm or British-Swedish pharmaceutical company AstraZeneca, to obtain Covid-19 vaccines for Malaysia."

https://codeblue.galencentre.org/2020/10/13/malaysia-may-get-chinese-c...

KUALA LUMPUR, Oct 13 — A Covid-19 vaccine from China may be deployed in Malaysia by the end of the year, Muhyiddin Yassin said today.
........................

"At the same time, the prime minister also stated that Malaysia can make its own bilateral agreements outside COVAX, such as with China’s state-owned pharmaceutical company Sinopharm or British-Swedish pharmaceutical company AstraZeneca, to obtain Covid-19 vaccines for Malaysia."

https://codeblue.galencentre.org/2020/10/13/malaysia-may-get-chinese-c...

KUALA LUMPUR, Oct 13 — A Covid-19 vaccine from China may be deployed in Malaysia by the end of the year, Muhyiddin Yassin said today.
........................

"At the same time, the prime minister also stated that Malaysia can make its own bilateral agreements outside COVAX, such as with China’s state-owned pharmaceutical company Sinopharm or British-Swedish pharmaceutical company AstraZeneca, to obtain Covid-19 vaccines for Malaysia."

https://codeblue.galencentre.org/2020/10/13/malaysia-may-get-chinese-c...

DrHash, I am going to stick a RM10 note on my computer. LOL

I reloaded today at .20. I am convinced this stock can fly far.

It is as clear as daylight Sinopharm is a front runner for Malaysia

KUALA LUMPUR, Oct 13 — A Covid-19 vaccine from China may be deployed in Malaysia by the end of the year, Muhyiddin Yassin said today.
........................

"At the same time, the prime minister also stated that Malaysia can make its own bilateral agreements outside COVAX, such as with China’s state-owned pharmaceutical company Sinopharm or British-Swedish pharmaceutical company AstraZeneca, to obtain Covid-19 vaccines for Malaysia."

https://codeblue.galencentre.org/2020/10/13/malaysia-may-get-chinese-c...

Waiting for Budget announcement

@ DrHash, Any new testing of Covid19 vaccine will have big challenge few years from now as mass vaccination take place globally. It is not possible to test vaccine without widespread infection.

KJ already mentioned in his interview if private sector supply direct to private hospitals, there’s nothing anyone can do and the money is in private healthcare. Pharma and Dpharma is for public sector purchases.